For years I have run a casual email
list serving the chiropractic profession, its students
and various interested non-chiropractor supporters.
Issue 14
16/10/07 13:44
Welcome to issue 14
"There is no worse tyranny than to force a man to pay for what he does not
want merely because you think it would be good for him."
--Robert Heinlein
-=--=-
Evidence you need?
Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly
http://content.nejm.org/cgi/content/full/357/14/1373?query=TOC
ABSTRACT
Background Reliable estimates of the effectiveness of influenza vaccine among persons 65 years of age and older are important for informed vaccination policies and programs. Short-term studies may provide misleading pictures of long-term benefits, and residual confounding may have biased past results. This study examined the effectiveness of influenza vaccine in seniors over the long term while addressing potential bias and residual confounding in the results.
Methods Data were pooled from 18 cohorts of community-dwelling elderly members of one U.S. health maintenance organization (HMO) for 1990–1991 through 1999–2000 and of two other HMOs for 1996–1997 through 1999–2000. Logistic regression was used to estimate the effectiveness of the vaccine for the prevention of hospitalization for pneumonia or influenza and death after adjustment for important covariates. Additional analyses explored for evidence of bias and the potential effect of residual confounding.
Results There were 713,872 person-seasons of observation. Most high-risk medical conditions that were measured were more prevalent among vaccinated than among unvaccinated persons. Vaccination was associated with a 27% reduction in the risk of hospitalization for pneumonia or influenza (adjusted odds ratio, 0.73; 95% confidence interval [CI], 0.68 to 0.77) and a 48% reduction in the risk of death (adjusted odds ratio, 0.52; 95% CI, 0.50 to 0.55). Estimates were generally stable across age and risk subgroups. In the sensitivity analyses, we modeled the effect of a hypothetical unmeasured confounder that would have caused overestimation of vaccine effectiveness in the main analysis; vaccination was still associated with statistically significant — though lower — reductions in the risks of both hospitalization and death.
Conclusions During 10 seasons, influenza vaccination was associated with significant reductions in the risk of hospitalization for pneumonia or influenza and in the risk of death among community-dwelling elderly persons. Vaccine delivery to this high-priority group should be improved.
-=-=-=-
what is this... evil?
is it global? Or just American?
I dont know.
joe
https://www.jvsr.com/researchupdate/detail.asp?ID=1056
-=-=-
CLINICAL GUIDELINES
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
Roger Chou, MD; Amir Qaseem, MD, PhD, MHA; Vincenza Snow, MD; Donald Casey, MD, MPH, MBA; J. Thomas Cross, Jr, MD, MPH; Paul Shekelle, MD, PhD; Douglas K. Owens, MD, MS, for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel*
2 October 2007 | Volume 147 Issue 7 | Pages 478-491
Recommendation 1: Clinicians should conduct a focused history and physical examination to help place patients with low back pain into 1 of 3 broad categories: nonspecific low back pain, back pain potentially associated with radiculopathy or spinal stenosis, or back pain potentially associated with another specific spinal cause. The history should include assessment of psychosocial risk factors, which predict risk for chronic disabling back pain (strong recommendation, moderate-quality evidence).
Recommendation 2: Clinicians should not routinely obtain imaging or other diagnostic tests in patients with nonspecific low back pain (strong recommendation, moderate-quality evidence).
Recommendation 3: Clinicians should perform diagnostic imaging and testing for patients with low back pain when severe or progressive neurologic deficits are present or when serious underlying conditions are suspected on the basis of history and physical examination (strong recommendation, moderate-quality evidence).
Recommendation 4: Clinicians should evaluate patients with persistent low back pain and signs or symptoms of radiculopathy or spinal stenosis with magnetic resonance imaging (preferred) or computed tomography only if they are potential candidates for surgery or epidural steroid injection (for suspected radiculopathy) (strong recommendation, moderate-quality evidence).
Recommendation 5: Clinicians should provide patients with evidence-based information on low back pain with regard to their expected course, advise patients to remain active, and provide information about effective self-care options (strong recommendation, moderate-quality evidence).
Recommendation 6: For patients with low back pain, clinicians should consider the use of medications with proven benefits in conjunction with back care information and self-care. Clinicians should assess severity of baseline pain and functional deficits, potential benefits, risks, and relative lack of long-term efficacy and safety data before initiating therapy (strong recommendation, moderate-quality evidence). For most patients, first-line medication options are acetaminophen or nonsteroidal anti-inflammatory drugs.
Recommendation 7: For patients who do not improve with self-care options, clinicians should consider the addition of nonpharmacologic therapy with proven benefits—for acute low back pain, spinal manipulation; for chronic or subacute low back pain, intensive interdisciplinary rehabilitation, exercise therapy, acupuncture, massage therapy, spinal manipulation, yoga, cognitive-behavioral therapy, or progressive relaxation (weak recommendation, moderate-quality evidence).
-=-=
-=-=-=
nothing is without risk, remember!
vaccines do cost the drug companies occasionally, according to this report, as well as making them squillions...but still no link to Autism.
WDDTY
Vaccine Damage: Parents receive $2bn compensation pay-outs
Vaccine manufacturers have paid out nearly $2bn in damages to parents in America whose children were harmed by one of the childhood jabs such as the MMR (measles-mumps-rubella) or DPT (diphtheria-pertussis-tetanus).
In all, around 2,000 families have received compensation payments that have averaged $850,000 each. There are a further 700 claims that are going through the pipeline.
None of the claims is for autism as medical researchers say they have failed to find a link between the disease and the MMR vaccine, despite the initial findings made by Dr Andrew Wakefield. Instead they are for a wide spectrum of physical and mental conditions that are likely to have been caused by one of the vaccinations.
Around 7,000 parents have filed a claim of an adverse reaction with America's Vaccine Injury Compensation Program (VICP). To win an award, the claimant must prove a causal link to a vaccine. As the medical establishment has refused to recognise any link to autism, the VICP has so far rejected 300 claims for this outright.
(Source: New England Journal of Medicine, 2007; 357: 1275-9).
Click here to receive health news by email.
Story from WDDTY:
http://www.wddty.com/03363800370060881833/vaccine-damage-parents-receive-2bn-compensation-pay-outs.html
Published: 04/10/2007 10:03:00 GMT
© WDDTY MMVI
-=-=-
this is quite amazing
war is hell
joe
To Print: Click your browser's PRINT button.
NOTE: To view the article with Web enhancements, go to:
http://www.medscape.com/viewarticle/563542
United States Prepares for Onslaught of War-Related Epilepsy
Caroline Cassels
Medscape Medical News 2007. © 2007 Medscape
September 28, 2007 — With traumatic brain injury (TBI) being the signature wound of the current conflicts in Iraq and Afghanistan, the US government is being asked to establish 6 epilepsy centers of excellence (CoEs) to identify, treat, and monitor the thousands of returning head-injured veterans at potential risk of developing posttraumatic epilepsy (PTE).
Initiated by the American Academy of Neurology (AAN), the Epilepsy Centers of Excellence Act of 2007 is currently before the US Congress and expected to pass sometime in 2008.
The bill was proposed by the AAN in response to concerns from its members that the anticipated onslaught of returning veterans with traumatic brain injury (TBI) who will ultimately develop PTE would outstrip the capacity of the Veterans Health Administration to adequately manage large numbers of such individuals.
"There was a great deal of concern among our members that much of this traumatic brain injury among returning vets was, over time, going to manifest itself in [posttraumatic] epilepsy and that the Veterans Administration [VA] was terribly unprepared for this," Mike Amery, who is the AAN legislative counsel at its Office for Federal Affairs, told Medscape Neurology & Neurosurgery.
Data from the Vietnam War show that 53% of soldiers who survived penetrating head wounds subsequently developed posttraumatic epilepsy, some up to 15 years later, says John Booss, MD, former national director, neurology service, Department of Veterans Affairs, who is also a member of the AAN Legislative Affairs Committee and a volunteer advocate for the proposed legislation.
Unprecedented Numbers of Closed Brain Injury
Dr. Booss told Medscape Neurology & Neurosurgery that in the current conflict, various factors, including Kevlar body armor and helmets, have made penetrating wounds — and specifically penetrating head wounds — much less common.
However, the widespread use of improvised explosive devices (IEDs), also known as roadside bombs, by insurgents in Iraq and Afghanistan, coupled with improved survival, is contributing to an unprecedented number of concussive closed head injuries.
The US government has cited national security concerns for not making an official total of the numbers of returning troops who have been treated for TBI publicly available. However, a position paper published earlier this year by the Brain Injury Association of America estimates that as of March 24, 2007, a total of 12,274 US service members have sustained a TBI in either Iraq or Afghanistan but projects this number "could grow as high as 150,000."
Other estimates assert that 22% of all returning service personnel have some form of TBI, 69% of whom were injured by roadside bombs, rocket-propelled grenades, and other blasts. TBI screening, which began in August 2007 at the National Naval Medical Center, showed 83% of wounded Marines and sailors had brain injuries.
Although the US Department of Defense supports mass TBI screening for all returning troops, currently it does not have the resources or a standardized screening process in place.
Exactly what proportion of brain-injured soldiers will subsequently develop PTE is uncertain, but according to Dr. Booss, it is likely to be significant. He points out that even "mild" TBI can trigger subsequent epilepsy.
"In the civilian sector, the rate of epilepsy from closed head injuries is somewhere just under 5%. In the military, it ranges from about 6% to 14%, but in all candor, at this point we simply don't know," Dr. Booss said.
"What we do know is the [Veterans Health Administration] is not prepared to handle an influx of veterans with TBI, a significant percentage of whom will develop epilepsy. However, this is something we believe this legislation will remedy."
Enormous Research Need
If passed, the bill will establish 6 epilepsy CoEs strategically distributed around the country. Through a competitive process, healthcare facilities affiliated with an academic research center would be invited to submit proposals for consideration by an expert peer-review panel that will assess their scientific and clinical merits.
Under the legislation, each center would receive $1 million per year for 4 years, with a mandate to conduct research, education, and clinical care activities. "This is really just seed money to get the centers started," said Mr. Amery. "The real money will come from grants and the participation of other research institutions and foundations."
According to Dr. Booss, there is an "enormous need" for TBI research with respect to both post-TBI sequelae, including epilepsy, and the psychosocial integration aspects of these injuries.
Many veterans, he said, have masked brain injuries and require systematic screening
Once a world leader in epilepsy research, the Veterans Health Administration saw funding for epilepsy research and care dry up during the mid-1990s as an unintended consequence of a major reorganization of the VA health care system..
"The VA epilepsy centers literally went from a position of international leadership to, in many instances, falling below community standards. As a result, many were shut down or saw services dramatically cut," said Dr. Booss.
Funding Stability Critical
The aim of the current legislation, said Dr. Booss, is to create a permanent, nationally organized hierarchy of care so that no matter where a veteran lives in the United States there will be a network of referral centers affiliated with a regional epilepsy CoE.
According to Mr. Amery, the model for the epilepsy CoEs is based on similar CoEs for Parkinson's disease (PD) and multiple sclerosis (MS) that have been established over the past 4 to 6 years and been successful.
However, there was a potential threat to continued funding with these centers. As a result, last year the AAN, along with other organizations, including the Parkinson's Action Network, the Paralyzed Veterans of America, and the National Multiple Sclerosis Society, successfully lobbied to have legislation passed that would permanently authorize funding.
Dr. Booss said the same must happen with the epilepsy CoEs. "The MS and PD centers of excellence were set up during my tenure [at the Department of Veterans Affairs], but there was no permanence associated with their establishment. We were very concerned that given other priorities, they might be allowed to wither or become victims of cutbacks, so the AAN mounted an effort to put into law permanent authorization of these centers, and the president signed the bill in December 2006," he said
"Funding stability is critically important to attracting the type of high-caliber researchers, clinicians, and educators that will ensure success of these centers. It is my hope that the epilepsy centers will also be permanently authorized by law," he added.
Spillover Effect
Rep. Ed Perlmutter, a Democrat from Colorado and the bill's sponsor, told Medscape Neurology & Neurosurgery that as the father of a young woman with epilepsy he has a personal interest in ensuring the legislation passes as quickly as possible.
A coordinated national approach to TBI and subsequent PTE, said Rep. Perlmutter, will ensure high-quality care for returning veterans. In addition, the mandated affiliation with established research institutions will benefit the larger epilepsy population; it is estimated that 3 million Americans, or 1% of the US population, has some form of epilepsy.
"The research and resulting medical advances will help the men and women who are serving our country and will also be very helpful to the [general] epilepsy population," said Rep. Perlmutter.
For more information visit www.aan.com/go/advocacy.
-=-=
can you trust a man called Edzard?
Dr Battistoni sent item below...
more on the man who is not only bringing chiropractic down, but anything else up for grabs by the drug companies?
joe
Begin forwarded message:
Ernst, Ernst, Ernst.
http://community.wddty.com/blogs/adverse_reactions/archive/2007/10/05/Herbicide.aspx
-=-=-
American Journal of Clinical Nutrition, Vol. 86, No. 4, 899-906, October 2007
© 2007 American Society for Nutrition
REVIEW ARTICLE
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease1,2,3
Richard J Johnson, Mark S Segal, Yuri Sautin, Takahiko Nakagawa, Daniel I Feig, Duk-Hee Kang, Michael S Gersch, Steven Benner and Laura G Sánchez-Lozada
1 From the Division of Nephrology and Department of Medicine, University of Florida, Gainesville, FL (RJJ, MSS, YS, TN, and MSG); the Division of Pediatric Nephrology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX (DIF); the Division of Nephrology, Ewha Woman's University College of Medicine, Seoul, Korea (D-HK); the Foundation for Applied Molecular Evolution, Gainesville, FL (SB); and the Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico (LGS-L)
Currently, we are experiencing an epidemic of cardiorenal disease characterized by increasing rates of obesity, hypertension, the metabolic syndrome, type 2 diabetes, and kidney disease. Whereas excessive caloric intake and physical inactivity are likely important factors driving the obesity epidemic, it is important to consider additional mechanisms. We revisit an old hypothesis that sugar, particularly excessive fructose intake, has a critical role in the epidemic of cardiorenal disease. We also present evidence that the unique ability of fructose to induce an increase in uric acid may be a major mechanism by which fructose can cause cardiorenal disease. Finally, we suggest that high intakes of fructose in African Americans may explain their greater predisposition to develop cardiorenal disease, and we provide a list of testable predictions to evaluate this hypothesis.
Key Words: Fructose • uric acid • sugar • arteriosclerosis • endothelial dysfunction • hypertension • obesity • chronic kidney disease • metabolic syndrome
-=-
American Journal of Clinical Nutrition, Vol. 86, No. 4, 1243-1247, October 2007
© 2007 American Society for Nutrition
ORIGINAL RESEARCH COMMUNICATION
Tea drinking is associated with benefits on bone density in older women1,2,3
Amanda Devine, Jonathan M Hodgson, Ian M Dick and Richard L Prince
1 From the School of Medicine and Pharmacology, University of Western Australia, Perth, Australia (JMH, IMD, and RLP); the Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth, Australia (IMD and RLP); and the School of Exercise, Biomedical and Health Science, Edith Cowan University, Joondalup, Australia (AD)
Background: Impaired hip structure assessed by dual-energy X-ray absorptiometry (DXA) areal bone mineral density (aBMD) is an independent predictor for osteoporotic hip fracture. Some studies suggest that tea intake may protect against bone loss.
Objective: Using both cross-sectional and longitudinal study designs, we examined the relation of tea consumption with hip structure.
Design: Randomly selected women (n = 1500) aged 70–85 y participated in a 5-y prospective trial to evaluate whether oral calcium supplements prevent osteoporotic fractures. aBMD at the hip was measured at years 1 and 5 with DXA. A cross-sectional analysis of 1027 of these women at 5 y assessed the relation of usual tea intake, measured by using a questionnaire, with aBMD. A prospective analysis of 164 women assessed the relation of tea intake at baseline, measured by using a 24-h dietary recall, with change in aBMD from years 1 to 5.
Results: In the cross-sectional analysis, total hip aBMD was 2.8% greater in tea drinkers (: 806; 95% CI: 797, 815 mg/cm2) than in non-tea drinkers (784; 764, 803 mg/cm2) (P < 0.05). In the prospective analysis over 4 y, tea drinkers lost an average of 1.6% of their total hip aBMD (–32; –45, –19 mg/cm2), but non-tea drinkers lost 4.0% (–13; –20, –5 mg/cm2) (P < 0.05). Adjustment for covariates did not influence the interpretation of results.
Conclusion: Tea drinking is associated with preservation of hip structure in elderly women. This finding provides further evidence of the beneficial effects of tea consumption on the skeleton.
Key Words: Tea drinking • cross-sectional study • prospective study • bone mineral density • fracture • elderly women
-=-=-=
Study: Cholesterol drugs' protection long-lasting
Story Highlights
Statins help prevent heart attacks for at least a decade after use ends
Next Article in Health »
(AP) -- Cholesterol-lowering statin drugs help prevent heart attacks for at least a decade after people stop taking them, the first long-term study of the world's top-selling type of medication finds.
The research follows up on a study in Scotland showing that men taking the drug Pravachol for five years substantially lowered their risk of heart attack and death from heart disease.
They were followed for 10 more years after most stopped taking the drug. That group was compared with a group of men who were given dummy pills during the five-year study. There was a 25 percent lower risk of heart attack or death from heart disease among those in the statin group, when compared with the placebo group.
The study participants were middle-aged men who had never had a heart attack but who had a very high average level of LDL, or bad cholesterol -- 192.
While the study found protection lasted after statin use stopped, the drugs usually are prescribed indefinitely, especially for people with known heart disease. Federal guidelines say these drugs are very safe and may be used by people with LDL levels as low as 130, or even 100 if they are at very high risk of heart attack.
The new results, based on medical records from more than 90 percent of the men in the original experiment, appear in Thursday's New England Journal of Medicine.
Don't Miss
NIH: Cholesterol Education Program
Health for Her: Alcohol and breast cancer
The researchers wrote that statin's protective effect was probably because existing plaque was stabilized and the progression of coronary artery disease was slowed.
"Continuing treatment after five years may be beneficial," they wrote.
After the original study ended in 1995, participants returned to their own doctor's care and decided whether to continue or start taking statins. Five years later, about 39 percent of the original statin patients were still taking the drugs, and 35 percent of the placebo takers were using statins.
Over the 15-year period, 619 of the original statin takers and 674 of the placebo takers died.
Dr. Michael J. Domanski of the National Heart, Lung, and Blood Institute said the study's biggest weakness is the fact that after the study ended, more of the original statin patients took the drugs than those in the placebo group.
The researchers argued that that difference couldn't explain the overall long-term protection demonstrated in the study.
Your Health Tools
MayoClinic.com: Health Library
Healthology: Health Video Library
Domanski wrote in an editorial that the study clearly shows the benefit of statin use "is durable over the long term" and that there now can be no doubt reducing levels of LDL cholesterol has a role in preventing and treating heart disease.
Still uncertain, he added, is how early people with high cholesterol should start using statins and how low one's LDL should be for the most benefit.
Currently, the National Cholesterol Education Program, a federally funded advisory group, and leading heart doctor groups recommend cutting the LDL level to below 70 for patients at very high risk of a heart attack, below 100 for high-risk patients and below 130 for moderate-risk patients.
The follow-up study was partly funded by Bristol-Myers Squibb Co., the maker of Pravachol, and Daiichi Sankyo Inc., maker of the statin WelChol. All but one of the researchers reported receiving consulting fees, lecture fees or research grants from a total of five other pharmaceutical companies, four of which sell statins. E-mail to a friend
Copyright 2007 The Associated Press. All rights reserved.This material may not be published, broadcast, rewritten, or redistributed.
-=-=-=
Even the Sydney Children's Hospital a few years ago said cold medications were mostly garbage. Why dont we use the old time proven remedies? (like let the body heal itself, steam, hot drinks, honey, lemon, herbs, etc..) Are we in too much of a hurry?
joe
Makers pull cold medicines sold for infants
(CNN) -- The makers of several leading over-the-counter cold medications are voluntarily withdrawing products sold for infants, the Consumer Healthcare Products Association said Thursday.
The Consumer Healthcare Products Association recommends not using cold medicines for kids under 2.
The trade group said the products were being withdrawn "out of an abundance of caution" and insisted the products are safe when used as directed.
"The reason the makers of over-the-counter, oral cough and cold medicines for infants are voluntarily withdrawing these medicines is that there have been rare patterns of misuse leading to overdose recently identified, particularly in infants, and safety is our top priority," Linda A. Suydam, the association's president, said in a statement.
"It's important to point out that these medicines are safe and effective when used as directed, and most parents are using them appropriately," she said.
CVS stores planned to stop selling the withdrawn products and store-brand equivalents, it said. Refunds are being offered if customers return the products. Watch Dr. Sanjay Gupta on whether the medicines are effective »
Withdrawn Medicines
Dimetapp
Decongestant Plus Cough Infant Drops
Decongestant Infant Drops
Little Colds
Decongestant Plus Cough
Multi-Symptom Cold Formula
Pediacare
Infant Drops Decongestant (containing pseudoephedrine)
Infant Drops Decongestant & Cough (containing pseudoephedrine)
Infant Dropper Decongestant (containing phenylephrine)
Infant Dropper Long-Acting Cough
Infant Dropper Decongestant & Cough (containing phenylephrine)
Robitussin
Infant Cough DM Drops
Triaminic
Infant & Toddler Thin Strips Decongestant
Infant & Toddler Thin Strips Decongestant Plus Cough
Tylenol
Concentrated Infants' Drops Plus Cold
Concentrated Infants' Drops Plus Cold & Cough
Last month, federal health officials recommended that the "consult your physician" advice to parents on the labels of cold and cough medicines aimed at young children be dropped and a warning not to use the medications in children under 2 be added. The U.S. Food and Drug Administration will officially consider revising the labels at a meeting next week.
After reviewing reports of side effects over the last four decades, the FDA found 54 child fatalities from over-the-counter decongestant medicines.
The agency found 69 reports of children's deaths connected with antihistamines, which are used to treat runny noses.
Baltimore health commissioner Dr. Joshua Sharfstein and other health officials in Maryland had requested a review by the FDA, saying 900 children under four in Maryland had overdosed on the products in 2004.
"When it comes to children under age two there are no recommended doses on these products so it's not reasonable to claim they are safe and effective when used as directed," Sharfstein told The Associated Press on Thursday.
Consumer Healthcare Products Association is a trade group representing U.S. manufacturers and distributors of over-the-counter medications and nutritional supplements.
The withdrawal does not affect medicines intended for children ages 2 and older.
The association said it would back any FDA move to change the advice on oral children's cough medicine.
CNN's Dr. Sanjay Gupta said over-the-counter cold medicines can cause side effects such as sedation, irritability, allergy and heart abnormalities.
Instead of the drugs, Gupta said, parents of sick infants can use vaporizers or hydrators, saline nose drops, rubber nose bulbs, and chicken soup and other fluids to keep an infant hydrated. E-mail to a friend
Copyright 2007 CNN. All rights reserved.This material may not be published, broadcast, rewritten, or redistributed. Associated Press contributed to this report.
-=-=-
40 hospital complaints since miscarriage
1:39pm The head of Royal North Shore's new complaints body says there have been 40 cases since the incident when a pregnant woman miscarried in an emergency room toilet. more
Get your kids checked free.
-=-=-=-
yes!
they published the comment
here
joe
http://pediatrics.aappublications.org/cgi/content/full/119/1/e275?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=spinal+manipulation&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT
Begin forwarded message:
From: Joseph Ieranò
Date: 14 October 2007 9:47:40 PM
To: infoierano
Cc: weeklydigest
Subject: I sent this comment
This article was published in Pediatrics, sadly:
http://pediatrics.aappublications.org/cgi/content/full/119/1/e275?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=spinal+manipulation&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT
my response is here, freshly sent....dont know if they'll add it
this is the sort of feedback forum that chiropractors are notably absent from...SEE the feedback under the article: ONLY ONE submission!
no wonder they ignore us
oh well hope they put this up there
joe
Flawed paper stirs a profession.
Joseph J. Ierano,
Doctor of Chiropractic
Private, solo practice of chiropractic.
Send letter to journal:
Re: Flawed paper stirs a profession.
E-mail Joseph J. Ierano
Chiropractic is at times a very nervous profession. Especially unnerving is a paper that addresses a serious subject, necessary in its execution, flawed in its production.
A meta-analysis such as this simply re-states the flaws of other studies; work done by others of dubious merit.
Dubious merit because there is no examination of the uniformity of interventions administered in the studies which they categorise at "spinal manipulation". Examination of a procedure surely deliniates that procedure in detail and presents it to the reader. Just what is "pediatric spinal manipulation"?
This study is what it is: a precurser to the study being rightly done. Lets just see what the adverse effects are of this procedure which seems to define chiropractors. But first, define the procedure, and don't make any serious assumptions until that scientific method is applied properly.
This may sound unbelievable, but In my experience (over a decade) of adjusting hundreds of children there has not been one event that could be categorised as "adverse". Similarly, in communication with my profession and state boards here in Australia, I do not think that one solitary action of litigation against a chiropractor has been brought for seriously harming or death of a child in administrering care. Is this not an astounding statistic in comparison with proper medical paediatric care? Bring on the science, please.
Conflict of Interest:
Registered Chiropractor educated in University-based undergraduate paediatric chiropractic and post- graduate specialisation in upper cervical chiropractic.
"There is no worse tyranny than to force a man to pay for what he does not
want merely because you think it would be good for him."
--Robert Heinlein
-=--=-
Evidence you need?
Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly
http://content.nejm.org/cgi/content/full/357/14/1373?query=TOC
ABSTRACT
Background Reliable estimates of the effectiveness of influenza vaccine among persons 65 years of age and older are important for informed vaccination policies and programs. Short-term studies may provide misleading pictures of long-term benefits, and residual confounding may have biased past results. This study examined the effectiveness of influenza vaccine in seniors over the long term while addressing potential bias and residual confounding in the results.
Methods Data were pooled from 18 cohorts of community-dwelling elderly members of one U.S. health maintenance organization (HMO) for 1990–1991 through 1999–2000 and of two other HMOs for 1996–1997 through 1999–2000. Logistic regression was used to estimate the effectiveness of the vaccine for the prevention of hospitalization for pneumonia or influenza and death after adjustment for important covariates. Additional analyses explored for evidence of bias and the potential effect of residual confounding.
Results There were 713,872 person-seasons of observation. Most high-risk medical conditions that were measured were more prevalent among vaccinated than among unvaccinated persons. Vaccination was associated with a 27% reduction in the risk of hospitalization for pneumonia or influenza (adjusted odds ratio, 0.73; 95% confidence interval [CI], 0.68 to 0.77) and a 48% reduction in the risk of death (adjusted odds ratio, 0.52; 95% CI, 0.50 to 0.55). Estimates were generally stable across age and risk subgroups. In the sensitivity analyses, we modeled the effect of a hypothetical unmeasured confounder that would have caused overestimation of vaccine effectiveness in the main analysis; vaccination was still associated with statistically significant — though lower — reductions in the risks of both hospitalization and death.
Conclusions During 10 seasons, influenza vaccination was associated with significant reductions in the risk of hospitalization for pneumonia or influenza and in the risk of death among community-dwelling elderly persons. Vaccine delivery to this high-priority group should be improved.
-=-=-=-
what is this... evil?
is it global? Or just American?
I dont know.
joe
https://www.jvsr.com/researchupdate/detail.asp?ID=1056
-=-=-
CLINICAL GUIDELINES
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
Roger Chou, MD; Amir Qaseem, MD, PhD, MHA; Vincenza Snow, MD; Donald Casey, MD, MPH, MBA; J. Thomas Cross, Jr, MD, MPH; Paul Shekelle, MD, PhD; Douglas K. Owens, MD, MS, for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel*
2 October 2007 | Volume 147 Issue 7 | Pages 478-491
Recommendation 1: Clinicians should conduct a focused history and physical examination to help place patients with low back pain into 1 of 3 broad categories: nonspecific low back pain, back pain potentially associated with radiculopathy or spinal stenosis, or back pain potentially associated with another specific spinal cause. The history should include assessment of psychosocial risk factors, which predict risk for chronic disabling back pain (strong recommendation, moderate-quality evidence).
Recommendation 2: Clinicians should not routinely obtain imaging or other diagnostic tests in patients with nonspecific low back pain (strong recommendation, moderate-quality evidence).
Recommendation 3: Clinicians should perform diagnostic imaging and testing for patients with low back pain when severe or progressive neurologic deficits are present or when serious underlying conditions are suspected on the basis of history and physical examination (strong recommendation, moderate-quality evidence).
Recommendation 4: Clinicians should evaluate patients with persistent low back pain and signs or symptoms of radiculopathy or spinal stenosis with magnetic resonance imaging (preferred) or computed tomography only if they are potential candidates for surgery or epidural steroid injection (for suspected radiculopathy) (strong recommendation, moderate-quality evidence).
Recommendation 5: Clinicians should provide patients with evidence-based information on low back pain with regard to their expected course, advise patients to remain active, and provide information about effective self-care options (strong recommendation, moderate-quality evidence).
Recommendation 6: For patients with low back pain, clinicians should consider the use of medications with proven benefits in conjunction with back care information and self-care. Clinicians should assess severity of baseline pain and functional deficits, potential benefits, risks, and relative lack of long-term efficacy and safety data before initiating therapy (strong recommendation, moderate-quality evidence). For most patients, first-line medication options are acetaminophen or nonsteroidal anti-inflammatory drugs.
Recommendation 7: For patients who do not improve with self-care options, clinicians should consider the addition of nonpharmacologic therapy with proven benefits—for acute low back pain, spinal manipulation; for chronic or subacute low back pain, intensive interdisciplinary rehabilitation, exercise therapy, acupuncture, massage therapy, spinal manipulation, yoga, cognitive-behavioral therapy, or progressive relaxation (weak recommendation, moderate-quality evidence).
-=-=
-=-=-=
nothing is without risk, remember!
vaccines do cost the drug companies occasionally, according to this report, as well as making them squillions...but still no link to Autism.
WDDTY
Vaccine Damage: Parents receive $2bn compensation pay-outs
Vaccine manufacturers have paid out nearly $2bn in damages to parents in America whose children were harmed by one of the childhood jabs such as the MMR (measles-mumps-rubella) or DPT (diphtheria-pertussis-tetanus).
In all, around 2,000 families have received compensation payments that have averaged $850,000 each. There are a further 700 claims that are going through the pipeline.
None of the claims is for autism as medical researchers say they have failed to find a link between the disease and the MMR vaccine, despite the initial findings made by Dr Andrew Wakefield. Instead they are for a wide spectrum of physical and mental conditions that are likely to have been caused by one of the vaccinations.
Around 7,000 parents have filed a claim of an adverse reaction with America's Vaccine Injury Compensation Program (VICP). To win an award, the claimant must prove a causal link to a vaccine. As the medical establishment has refused to recognise any link to autism, the VICP has so far rejected 300 claims for this outright.
(Source: New England Journal of Medicine, 2007; 357: 1275-9).
Click here to receive health news by email.
Story from WDDTY:
http://www.wddty.com/03363800370060881833/vaccine-damage-parents-receive-2bn-compensation-pay-outs.html
Published: 04/10/2007 10:03:00 GMT
© WDDTY MMVI
-=-=-
this is quite amazing
war is hell
joe
To Print: Click your browser's PRINT button.
NOTE: To view the article with Web enhancements, go to:
http://www.medscape.com/viewarticle/563542
United States Prepares for Onslaught of War-Related Epilepsy
Caroline Cassels
Medscape Medical News 2007. © 2007 Medscape
September 28, 2007 — With traumatic brain injury (TBI) being the signature wound of the current conflicts in Iraq and Afghanistan, the US government is being asked to establish 6 epilepsy centers of excellence (CoEs) to identify, treat, and monitor the thousands of returning head-injured veterans at potential risk of developing posttraumatic epilepsy (PTE).
Initiated by the American Academy of Neurology (AAN), the Epilepsy Centers of Excellence Act of 2007 is currently before the US Congress and expected to pass sometime in 2008.
The bill was proposed by the AAN in response to concerns from its members that the anticipated onslaught of returning veterans with traumatic brain injury (TBI) who will ultimately develop PTE would outstrip the capacity of the Veterans Health Administration to adequately manage large numbers of such individuals.
"There was a great deal of concern among our members that much of this traumatic brain injury among returning vets was, over time, going to manifest itself in [posttraumatic] epilepsy and that the Veterans Administration [VA] was terribly unprepared for this," Mike Amery, who is the AAN legislative counsel at its Office for Federal Affairs, told Medscape Neurology & Neurosurgery.
Data from the Vietnam War show that 53% of soldiers who survived penetrating head wounds subsequently developed posttraumatic epilepsy, some up to 15 years later, says John Booss, MD, former national director, neurology service, Department of Veterans Affairs, who is also a member of the AAN Legislative Affairs Committee and a volunteer advocate for the proposed legislation.
Unprecedented Numbers of Closed Brain Injury
Dr. Booss told Medscape Neurology & Neurosurgery that in the current conflict, various factors, including Kevlar body armor and helmets, have made penetrating wounds — and specifically penetrating head wounds — much less common.
However, the widespread use of improvised explosive devices (IEDs), also known as roadside bombs, by insurgents in Iraq and Afghanistan, coupled with improved survival, is contributing to an unprecedented number of concussive closed head injuries.
The US government has cited national security concerns for not making an official total of the numbers of returning troops who have been treated for TBI publicly available. However, a position paper published earlier this year by the Brain Injury Association of America estimates that as of March 24, 2007, a total of 12,274 US service members have sustained a TBI in either Iraq or Afghanistan but projects this number "could grow as high as 150,000."
Other estimates assert that 22% of all returning service personnel have some form of TBI, 69% of whom were injured by roadside bombs, rocket-propelled grenades, and other blasts. TBI screening, which began in August 2007 at the National Naval Medical Center, showed 83% of wounded Marines and sailors had brain injuries.
Although the US Department of Defense supports mass TBI screening for all returning troops, currently it does not have the resources or a standardized screening process in place.
Exactly what proportion of brain-injured soldiers will subsequently develop PTE is uncertain, but according to Dr. Booss, it is likely to be significant. He points out that even "mild" TBI can trigger subsequent epilepsy.
"In the civilian sector, the rate of epilepsy from closed head injuries is somewhere just under 5%. In the military, it ranges from about 6% to 14%, but in all candor, at this point we simply don't know," Dr. Booss said.
"What we do know is the [Veterans Health Administration] is not prepared to handle an influx of veterans with TBI, a significant percentage of whom will develop epilepsy. However, this is something we believe this legislation will remedy."
Enormous Research Need
If passed, the bill will establish 6 epilepsy CoEs strategically distributed around the country. Through a competitive process, healthcare facilities affiliated with an academic research center would be invited to submit proposals for consideration by an expert peer-review panel that will assess their scientific and clinical merits.
Under the legislation, each center would receive $1 million per year for 4 years, with a mandate to conduct research, education, and clinical care activities. "This is really just seed money to get the centers started," said Mr. Amery. "The real money will come from grants and the participation of other research institutions and foundations."
According to Dr. Booss, there is an "enormous need" for TBI research with respect to both post-TBI sequelae, including epilepsy, and the psychosocial integration aspects of these injuries.
Many veterans, he said, have masked brain injuries and require systematic screening
Once a world leader in epilepsy research, the Veterans Health Administration saw funding for epilepsy research and care dry up during the mid-1990s as an unintended consequence of a major reorganization of the VA health care system..
"The VA epilepsy centers literally went from a position of international leadership to, in many instances, falling below community standards. As a result, many were shut down or saw services dramatically cut," said Dr. Booss.
Funding Stability Critical
The aim of the current legislation, said Dr. Booss, is to create a permanent, nationally organized hierarchy of care so that no matter where a veteran lives in the United States there will be a network of referral centers affiliated with a regional epilepsy CoE.
According to Mr. Amery, the model for the epilepsy CoEs is based on similar CoEs for Parkinson's disease (PD) and multiple sclerosis (MS) that have been established over the past 4 to 6 years and been successful.
However, there was a potential threat to continued funding with these centers. As a result, last year the AAN, along with other organizations, including the Parkinson's Action Network, the Paralyzed Veterans of America, and the National Multiple Sclerosis Society, successfully lobbied to have legislation passed that would permanently authorize funding.
Dr. Booss said the same must happen with the epilepsy CoEs. "The MS and PD centers of excellence were set up during my tenure [at the Department of Veterans Affairs], but there was no permanence associated with their establishment. We were very concerned that given other priorities, they might be allowed to wither or become victims of cutbacks, so the AAN mounted an effort to put into law permanent authorization of these centers, and the president signed the bill in December 2006," he said
"Funding stability is critically important to attracting the type of high-caliber researchers, clinicians, and educators that will ensure success of these centers. It is my hope that the epilepsy centers will also be permanently authorized by law," he added.
Spillover Effect
Rep. Ed Perlmutter, a Democrat from Colorado and the bill's sponsor, told Medscape Neurology & Neurosurgery that as the father of a young woman with epilepsy he has a personal interest in ensuring the legislation passes as quickly as possible.
A coordinated national approach to TBI and subsequent PTE, said Rep. Perlmutter, will ensure high-quality care for returning veterans. In addition, the mandated affiliation with established research institutions will benefit the larger epilepsy population; it is estimated that 3 million Americans, or 1% of the US population, has some form of epilepsy.
"The research and resulting medical advances will help the men and women who are serving our country and will also be very helpful to the [general] epilepsy population," said Rep. Perlmutter.
For more information visit www.aan.com/go/advocacy.
-=-=
can you trust a man called Edzard?
Dr Battistoni sent item below...
more on the man who is not only bringing chiropractic down, but anything else up for grabs by the drug companies?
joe
Begin forwarded message:
Ernst, Ernst, Ernst.
http://community.wddty.com/blogs/adverse_reactions/archive/2007/10/05/Herbicide.aspx
-=-=-
American Journal of Clinical Nutrition, Vol. 86, No. 4, 899-906, October 2007
© 2007 American Society for Nutrition
REVIEW ARTICLE
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease1,2,3
Richard J Johnson, Mark S Segal, Yuri Sautin, Takahiko Nakagawa, Daniel I Feig, Duk-Hee Kang, Michael S Gersch, Steven Benner and Laura G Sánchez-Lozada
1 From the Division of Nephrology and Department of Medicine, University of Florida, Gainesville, FL (RJJ, MSS, YS, TN, and MSG); the Division of Pediatric Nephrology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX (DIF); the Division of Nephrology, Ewha Woman's University College of Medicine, Seoul, Korea (D-HK); the Foundation for Applied Molecular Evolution, Gainesville, FL (SB); and the Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico (LGS-L)
Currently, we are experiencing an epidemic of cardiorenal disease characterized by increasing rates of obesity, hypertension, the metabolic syndrome, type 2 diabetes, and kidney disease. Whereas excessive caloric intake and physical inactivity are likely important factors driving the obesity epidemic, it is important to consider additional mechanisms. We revisit an old hypothesis that sugar, particularly excessive fructose intake, has a critical role in the epidemic of cardiorenal disease. We also present evidence that the unique ability of fructose to induce an increase in uric acid may be a major mechanism by which fructose can cause cardiorenal disease. Finally, we suggest that high intakes of fructose in African Americans may explain their greater predisposition to develop cardiorenal disease, and we provide a list of testable predictions to evaluate this hypothesis.
Key Words: Fructose • uric acid • sugar • arteriosclerosis • endothelial dysfunction • hypertension • obesity • chronic kidney disease • metabolic syndrome
-=-
American Journal of Clinical Nutrition, Vol. 86, No. 4, 1243-1247, October 2007
© 2007 American Society for Nutrition
ORIGINAL RESEARCH COMMUNICATION
Tea drinking is associated with benefits on bone density in older women1,2,3
Amanda Devine, Jonathan M Hodgson, Ian M Dick and Richard L Prince
1 From the School of Medicine and Pharmacology, University of Western Australia, Perth, Australia (JMH, IMD, and RLP); the Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth, Australia (IMD and RLP); and the School of Exercise, Biomedical and Health Science, Edith Cowan University, Joondalup, Australia (AD)
Background: Impaired hip structure assessed by dual-energy X-ray absorptiometry (DXA) areal bone mineral density (aBMD) is an independent predictor for osteoporotic hip fracture. Some studies suggest that tea intake may protect against bone loss.
Objective: Using both cross-sectional and longitudinal study designs, we examined the relation of tea consumption with hip structure.
Design: Randomly selected women (n = 1500) aged 70–85 y participated in a 5-y prospective trial to evaluate whether oral calcium supplements prevent osteoporotic fractures. aBMD at the hip was measured at years 1 and 5 with DXA. A cross-sectional analysis of 1027 of these women at 5 y assessed the relation of usual tea intake, measured by using a questionnaire, with aBMD. A prospective analysis of 164 women assessed the relation of tea intake at baseline, measured by using a 24-h dietary recall, with change in aBMD from years 1 to 5.
Results: In the cross-sectional analysis, total hip aBMD was 2.8% greater in tea drinkers (: 806; 95% CI: 797, 815 mg/cm2) than in non-tea drinkers (784; 764, 803 mg/cm2) (P < 0.05). In the prospective analysis over 4 y, tea drinkers lost an average of 1.6% of their total hip aBMD (–32; –45, –19 mg/cm2), but non-tea drinkers lost 4.0% (–13; –20, –5 mg/cm2) (P < 0.05). Adjustment for covariates did not influence the interpretation of results.
Conclusion: Tea drinking is associated with preservation of hip structure in elderly women. This finding provides further evidence of the beneficial effects of tea consumption on the skeleton.
Key Words: Tea drinking • cross-sectional study • prospective study • bone mineral density • fracture • elderly women
-=-=-=
Study: Cholesterol drugs' protection long-lasting
Story Highlights
Statins help prevent heart attacks for at least a decade after use ends
Next Article in Health »
(AP) -- Cholesterol-lowering statin drugs help prevent heart attacks for at least a decade after people stop taking them, the first long-term study of the world's top-selling type of medication finds.
The research follows up on a study in Scotland showing that men taking the drug Pravachol for five years substantially lowered their risk of heart attack and death from heart disease.
They were followed for 10 more years after most stopped taking the drug. That group was compared with a group of men who were given dummy pills during the five-year study. There was a 25 percent lower risk of heart attack or death from heart disease among those in the statin group, when compared with the placebo group.
The study participants were middle-aged men who had never had a heart attack but who had a very high average level of LDL, or bad cholesterol -- 192.
While the study found protection lasted after statin use stopped, the drugs usually are prescribed indefinitely, especially for people with known heart disease. Federal guidelines say these drugs are very safe and may be used by people with LDL levels as low as 130, or even 100 if they are at very high risk of heart attack.
The new results, based on medical records from more than 90 percent of the men in the original experiment, appear in Thursday's New England Journal of Medicine.
Don't Miss
NIH: Cholesterol Education Program
Health for Her: Alcohol and breast cancer
The researchers wrote that statin's protective effect was probably because existing plaque was stabilized and the progression of coronary artery disease was slowed.
"Continuing treatment after five years may be beneficial," they wrote.
After the original study ended in 1995, participants returned to their own doctor's care and decided whether to continue or start taking statins. Five years later, about 39 percent of the original statin patients were still taking the drugs, and 35 percent of the placebo takers were using statins.
Over the 15-year period, 619 of the original statin takers and 674 of the placebo takers died.
Dr. Michael J. Domanski of the National Heart, Lung, and Blood Institute said the study's biggest weakness is the fact that after the study ended, more of the original statin patients took the drugs than those in the placebo group.
The researchers argued that that difference couldn't explain the overall long-term protection demonstrated in the study.
Your Health Tools
MayoClinic.com: Health Library
Healthology: Health Video Library
Domanski wrote in an editorial that the study clearly shows the benefit of statin use "is durable over the long term" and that there now can be no doubt reducing levels of LDL cholesterol has a role in preventing and treating heart disease.
Still uncertain, he added, is how early people with high cholesterol should start using statins and how low one's LDL should be for the most benefit.
Currently, the National Cholesterol Education Program, a federally funded advisory group, and leading heart doctor groups recommend cutting the LDL level to below 70 for patients at very high risk of a heart attack, below 100 for high-risk patients and below 130 for moderate-risk patients.
The follow-up study was partly funded by Bristol-Myers Squibb Co., the maker of Pravachol, and Daiichi Sankyo Inc., maker of the statin WelChol. All but one of the researchers reported receiving consulting fees, lecture fees or research grants from a total of five other pharmaceutical companies, four of which sell statins. E-mail to a friend
Copyright 2007 The Associated Press. All rights reserved.This material may not be published, broadcast, rewritten, or redistributed.
-=-=-=
Even the Sydney Children's Hospital a few years ago said cold medications were mostly garbage. Why dont we use the old time proven remedies? (like let the body heal itself, steam, hot drinks, honey, lemon, herbs, etc..) Are we in too much of a hurry?
joe
Makers pull cold medicines sold for infants
(CNN) -- The makers of several leading over-the-counter cold medications are voluntarily withdrawing products sold for infants, the Consumer Healthcare Products Association said Thursday.
The Consumer Healthcare Products Association recommends not using cold medicines for kids under 2.
The trade group said the products were being withdrawn "out of an abundance of caution" and insisted the products are safe when used as directed.
"The reason the makers of over-the-counter, oral cough and cold medicines for infants are voluntarily withdrawing these medicines is that there have been rare patterns of misuse leading to overdose recently identified, particularly in infants, and safety is our top priority," Linda A. Suydam, the association's president, said in a statement.
"It's important to point out that these medicines are safe and effective when used as directed, and most parents are using them appropriately," she said.
CVS stores planned to stop selling the withdrawn products and store-brand equivalents, it said. Refunds are being offered if customers return the products. Watch Dr. Sanjay Gupta on whether the medicines are effective »
Withdrawn Medicines
Dimetapp
Decongestant Plus Cough Infant Drops
Decongestant Infant Drops
Little Colds
Decongestant Plus Cough
Multi-Symptom Cold Formula
Pediacare
Infant Drops Decongestant (containing pseudoephedrine)
Infant Drops Decongestant & Cough (containing pseudoephedrine)
Infant Dropper Decongestant (containing phenylephrine)
Infant Dropper Long-Acting Cough
Infant Dropper Decongestant & Cough (containing phenylephrine)
Robitussin
Infant Cough DM Drops
Triaminic
Infant & Toddler Thin Strips Decongestant
Infant & Toddler Thin Strips Decongestant Plus Cough
Tylenol
Concentrated Infants' Drops Plus Cold
Concentrated Infants' Drops Plus Cold & Cough
Last month, federal health officials recommended that the "consult your physician" advice to parents on the labels of cold and cough medicines aimed at young children be dropped and a warning not to use the medications in children under 2 be added. The U.S. Food and Drug Administration will officially consider revising the labels at a meeting next week.
After reviewing reports of side effects over the last four decades, the FDA found 54 child fatalities from over-the-counter decongestant medicines.
The agency found 69 reports of children's deaths connected with antihistamines, which are used to treat runny noses.
Baltimore health commissioner Dr. Joshua Sharfstein and other health officials in Maryland had requested a review by the FDA, saying 900 children under four in Maryland had overdosed on the products in 2004.
"When it comes to children under age two there are no recommended doses on these products so it's not reasonable to claim they are safe and effective when used as directed," Sharfstein told The Associated Press on Thursday.
Consumer Healthcare Products Association is a trade group representing U.S. manufacturers and distributors of over-the-counter medications and nutritional supplements.
The withdrawal does not affect medicines intended for children ages 2 and older.
The association said it would back any FDA move to change the advice on oral children's cough medicine.
CNN's Dr. Sanjay Gupta said over-the-counter cold medicines can cause side effects such as sedation, irritability, allergy and heart abnormalities.
Instead of the drugs, Gupta said, parents of sick infants can use vaporizers or hydrators, saline nose drops, rubber nose bulbs, and chicken soup and other fluids to keep an infant hydrated. E-mail to a friend
Copyright 2007 CNN. All rights reserved.This material may not be published, broadcast, rewritten, or redistributed. Associated Press contributed to this report.
-=-=-
40 hospital complaints since miscarriage
1:39pm The head of Royal North Shore's new complaints body says there have been 40 cases since the incident when a pregnant woman miscarried in an emergency room toilet. more
Get your kids checked free.
-=-=-=-
yes!
they published the comment
here
joe
http://pediatrics.aappublications.org/cgi/content/full/119/1/e275?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=spinal+manipulation&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT
Begin forwarded message:
From: Joseph Ieranò
Date: 14 October 2007 9:47:40 PM
To: infoierano
Cc: weeklydigest
Subject: I sent this comment
This article was published in Pediatrics, sadly:
http://pediatrics.aappublications.org/cgi/content/full/119/1/e275?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=spinal+manipulation&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT
my response is here, freshly sent....dont know if they'll add it
this is the sort of feedback forum that chiropractors are notably absent from...SEE the feedback under the article: ONLY ONE submission!
no wonder they ignore us
oh well hope they put this up there
joe
Flawed paper stirs a profession.
Joseph J. Ierano,
Doctor of Chiropractic
Private, solo practice of chiropractic.
Send letter to journal:
Re: Flawed paper stirs a profession.
E-mail Joseph J. Ierano
Chiropractic is at times a very nervous profession. Especially unnerving is a paper that addresses a serious subject, necessary in its execution, flawed in its production.
A meta-analysis such as this simply re-states the flaws of other studies; work done by others of dubious merit.
Dubious merit because there is no examination of the uniformity of interventions administered in the studies which they categorise at "spinal manipulation". Examination of a procedure surely deliniates that procedure in detail and presents it to the reader. Just what is "pediatric spinal manipulation"?
This study is what it is: a precurser to the study being rightly done. Lets just see what the adverse effects are of this procedure which seems to define chiropractors. But first, define the procedure, and don't make any serious assumptions until that scientific method is applied properly.
This may sound unbelievable, but In my experience (over a decade) of adjusting hundreds of children there has not been one event that could be categorised as "adverse". Similarly, in communication with my profession and state boards here in Australia, I do not think that one solitary action of litigation against a chiropractor has been brought for seriously harming or death of a child in administrering care. Is this not an astounding statistic in comparison with proper medical paediatric care? Bring on the science, please.
Conflict of Interest:
Registered Chiropractor educated in University-based undergraduate paediatric chiropractic and post- graduate specialisation in upper cervical chiropractic.